Dow Up 1.30% Nasdaq Up 0.37%

Sinovac Biotech Ltd. (SVA)

-NasdaqGS
5.44 0.07(1.30%) Oct 30, 4:00PM EDT
Prev Close:5.37
Open:5.37
Bid:4.80 x 200
Ask:N/A
1y Target Est:9.50
Beta:-0.28
Earnings Date:Nov 17 - Nov 21 (Est.)
Day's Range:5.25 - 5.47
52wk Range:4.51 - 8.14
Volume:47,777
Avg Vol (3m):194,406
Market Cap:302.81M
P/E (ttm):54.95
EPS (ttm):0.10
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SVA

Comparison

Symbol% ChgMkt Cap
SVAUp 1.30%302.81M
GSK108.52B
SNY119.93B

Key Statistics

Forward P/E (1 yr):60.44
P/S (ttm):4.23
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.04
Quarterly EPS Est (Sep-14) :-0.01
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-11.19

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sinovac Biotech Ltd., a biopharmaceutical company, is engaged in the research, development, manufacture, and commercialization of vaccines for hepatitis A, hepatitis B, and influenza viruses in the People's Republic of China. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback